- Home
- DRCT vs ASBP Comparison
DRCT vs ASBP Comparison
Compare DRCT & ASBP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- DRCT
- ASBP
- Stock Information
- Founded
- DRCT 2018
- ASBP 2021
- Country
- DRCT United States
- ASBP United States
- Employees
- DRCT N/A
- ASBP N/A
- Industry
- DRCT Computer Software: Programming Data Processing
- ASBP Biotechnology: Pharmaceutical Preparations
- Sector
- DRCT Technology
- ASBP Health Care
- Exchange
- DRCT Nasdaq
- ASBP Nasdaq
- Market Cap
- DRCT 16.7M
- ASBP 14.5M
- IPO Year
- DRCT 2022
- ASBP N/A
- Fundamental
- Price
- DRCT $0.55
- ASBP $0.32
- Analyst Decision
- DRCT Strong Buy
- ASBP
- Analyst Count
- DRCT 1
- ASBP 0
- Target Price
- DRCT $6.00
- ASBP N/A
- AVG Volume (30 Days)
- DRCT 153.1K
- ASBP 7.6M
- Earning Date
- DRCT 05-06-2025
- ASBP 08-24-2025
- Dividend Yield
- DRCT N/A
- ASBP N/A
- EPS Growth
- DRCT N/A
- ASBP N/A
- EPS
- DRCT N/A
- ASBP N/A
- Revenue
- DRCT $48,170,000.00
- ASBP N/A
- Revenue This Year
- DRCT $50.71
- ASBP N/A
- Revenue Next Year
- DRCT $26.31
- ASBP N/A
- P/E Ratio
- DRCT N/A
- ASBP N/A
- Revenue Growth
- DRCT N/A
- ASBP N/A
- 52 Week Low
- DRCT $0.44
- ASBP $0.22
- 52 Week High
- DRCT $6.59
- ASBP $15.80
- Technical
- Relative Strength Index (RSI)
- DRCT 44.03
- ASBP N/A
- Support Level
- DRCT $0.53
- ASBP N/A
- Resistance Level
- DRCT $0.63
- ASBP N/A
- Average True Range (ATR)
- DRCT 0.05
- ASBP 0.00
- MACD
- DRCT -0.00
- ASBP 0.00
- Stochastic Oscillator
- DRCT 12.67
- ASBP 0.00
About DRCT Direct Digital Holdings Inc.
Direct Digital Holdings Inc is an end-to-end, full-service programmatic advertising platform primarily focused on providing advertising technology, data-driven campaign optimization, and other solutions to underserved and less efficient markets on both the buy-side and sell-side of the digital advertising ecosystem. The company operates two reportable segments: sell-side advertising, which includes the results of Colossus Media, and buy-side advertising, which includes the results of Orange 142 and Huddled Masses. All of the company's revenues are attributed to the United States.
About ASBP Aspire Biopharma Holdings Inc. Common Stock
Aspire Biopharma Holdings Inc developing next-generation absorption of medicine that will have an impact on the opioid crisis. The group engaged in the business of developing and marketing disruptive technology for novel delivery mechanisms for do-no-harm drugs. Its nanotechnology drug formulation directly targets pain and inflammation bypassing the gastrointestinal tracts.